510(k) K003747
K003747 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "C1-INHIBITOR MICROTITER ASSAY DEVICE". The FDA issued a decision of Substantially Equivalent on March 19, 2001. The device falls under product code DBA (Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5250. Baxter Healthcare Corp has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 19, 2001
- Date Received
- December 4, 2000
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5250
- Review Panel
- IM
- Submission Type